In a 65-year-old man (97 kg, 1.74 m) with a history of right knee injury, pain on knee flexion and rotation, joint effusion and crepitus suggestive of osteoarthritis, which of the following statements is incorrect?

The INCORRECT Statement is C: Intra-articular corticosteroid injection is contraindicated

Statement C is definitively incorrect—intra-articular corticosteroid injections are specifically indicated, not contraindicated, in knee osteoarthritis with effusion. 1

Analysis of Each Statement

Statement A: Weight Loss Helps Alleviate Symptoms - CORRECT

This patient has a BMI of 32 kg/m² (97 kg, 1.74 m), classifying him as obese. Weight reduction is a core non-pharmacological recommendation for knee OA management 1, 2. The EULAR 2003 guidelines explicitly state that treatment should be tailored to knee risk factors including obesity, and weight reduction should be included in the management plan 1. The 2024 EULAR update reinforces that people with knee OA who are overweight or obese should be offered support to achieve and maintain weight loss 2.

Statement B: Baker's Cyst May Coexist - CORRECT

Baker's cysts (popliteal cysts) commonly occur in knee OA as a result of joint effusion. The presence of joint effusion in this patient makes coexisting Baker's cyst entirely plausible, as effusion can communicate with the posterior joint space forming these cysts.

Statement C: Intra-articular Corticosteroid Injection is Contraindicated - INCORRECT

This statement is false. The EULAR guidelines explicitly state: "Intra-articular injection of long acting corticosteroid is indicated for acute exacerbation of knee pain, especially if accompanied by effusion" 1. This patient presents with joint effusion, making him an ideal candidate for intra-articular steroid injection. The evidence shows:

• Intra-articular steroids are efficacious with Level 1B evidence 3
• Better outcomes are seen in patients with effusion 3
• Steroid injection provides short-term benefit (effective at one week, though benefit may diminish by 24 weeks) 3

There are no contraindications mentioned in this clinical scenario. The presence of effusion actually strengthens the indication for this treatment.

Statement D: Quadriceps Strengthening Exercises are Beneficial - CORRECT

Exercise programs including strength training are a core recommendation for knee OA with Level 1a evidence and Grade A strength 2. The 2024 EULAR guidelines state that all people with knee OA should be offered an exercise program (including strength, aerobic, flexibility, or neuromotor exercises) with adequate dosage and progression tailored to physical function 2. This is consistently recommended across all guideline iterations.

Statement E: NSAIDs More Effective Than Acetaminophen But More Side Effects - CORRECT

The evidence consistently shows NSAIDs have better efficacy than paracetamol (acetaminophen) but with increased gastrointestinal side effects 3. Specifically:

• A 2-year RCT comparing paracetamol with naproxen showed naproxen led to greater pain reductions (effect size 0.32 at 42 days, 0.45 at 730 days) 3
• Patient dropout was high: 65% due to lack of efficacy in the paracetamol arm and adverse events in the naproxen arm 3
• The guidelines note NSAIDs are "more efficacious than paracetamol but with increased gastrointestinal side effects" 3

This patient with effusion would particularly benefit from NSAIDs, as the guidelines suggest NSAIDs are logical in patients with clinically overt synovitis or effusion 3.

Clinical Approach for This Patient

Given this 65-year-old man with knee OA, effusion, and crepitus:

1. Immediate management: Intra-articular corticosteroid injection (indicated given the effusion) 1
2. Pharmacologic: Start with paracetamol up to 4g/day; if inadequate, advance to NSAIDs (particularly appropriate given effusion) 1
3. Non-pharmacologic core interventions:
   • Weight loss program (BMI 32) 1, 2
   • Quadriceps strengthening and exercise program 2
   • Patient education on self-management 1, 2